Literature DB >> 9238341

Somatosensory evoked potentials in migraine.

M de Tommaso1, V Sciruicchio, P Tota, M Megna, M Guido, S Genco, F Puca.   

Abstract

Twenty-six patients suffering from migraine with aura and without aura were examined using somatosensory evoked potentials (SEPs) during the intercritical phase. The mean amplitude of the prerolandic component was significantly reduced in migraine patients with and without aura on the right hemisphere; the ratio between the parietal N20/P25 and the prerolandic P22/N30 was significantly enhanced in migraine groups over the left and the right hemisphere. A significant interside asymmetry of the N30 amplitude was observed in the migraine with aura group in comparison with control subjects. The occurrence of SEP abnormalities was not correlated with the age of the patients, with illness duration or with the frequency of migraine attacks. SEP abnormalities observed in migraine with and without aura may have an underlying primary neural disorder probably based on a chronic dopaminergic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9238341

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  3 in total

Review 1.  Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence.

Authors:  Alejandro Labastida-Ramírez; Silvia Benemei; Maria Albanese; Antonina D'Amico; Giovanni Grillo; Oxana Grosu; Devrimsel Harika Ertem; Jasper Mecklenburg; Elena Petrovna Fedorova; Pavel Řehulka; Francesca Schiano di Cola; Javier Trigo Lopez; Nina Vashchenko; Antoinette MaassenVanDenBrink; Paolo Martelletti
Journal:  J Headache Pain       Date:  2020-05-24       Impact factor: 7.277

Review 2.  Clinical neurophysiology of migraine with aura.

Authors:  Gianluca Coppola; Cherubino Di Lorenzo; Vincenzo Parisi; Marco Lisicki; Mariano Serrao; Francesco Pierelli
Journal:  J Headache Pain       Date:  2019-04-29       Impact factor: 7.277

3.  Current understanding of cortical structure and function in migraine.

Authors:  Else A Tolner; Shih-Pin Chen; Katharina Eikermann-Haerter
Journal:  Cephalalgia       Date:  2019-03-28       Impact factor: 6.292

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.